Department of Pediatrics, University of California, San Francisco, CA, USA.
Department of Medicine, University of California, San Francisco, CA, USA.
J Asthma. 2021 Jul;58(7):893-902. doi: 10.1080/02770903.2020.1741612. Epub 2020 Mar 18.
are succinct, operational versions of evidence-based guidelines. Studies have demonstrated pathways improve quality of care for children hospitalized with asthma, but we have limited information on other key factors to guide hospital leaders and clinicians in pathway implementation efforts. Our objective was to evaluate the adoption, implementation, and reach of inpatient pediatric asthma pathways.
This was a mixed-methods study of hospitals participating in a national collaborative to implement pathways. Data sources included electronic surveys of implementation leaders and staff, field observations, and chart review of children ages 2-17 years admitted with a primary diagnosis of asthma. Outcomes included by hospitals, pathway factors, and of pathways to children hospitalized with asthma. Quantitative data were analyzed using descriptive statistics and multivariable regression. Qualitative data were analyzed using thematic content analysis.
Eighty-five hospitals enrolled; 68 (80%) adopted/completed the collaborative. These 68 hospitals implemented pathways with overall high fidelity, implementing a median of 5 of 5 core pathway components (Interquartile Range [IQR] 4-5) in a median of 5 months (IQR 3-9). Implementation teams reported a median time cost of 78 h (IQR: 40-120) for implementation. Implementation leaders reported the values of pathway implementation included improvements in care, enhanced interdisciplinary collaboration, and access to educational resources. Leaders reported barriers in modifying electronic health records (EHRs), and only 63% of children had electronic pathway orders placed.
Hospitals implemented pathways with high fidelity. Barriers in modifying EHRs may have limited the reach of pathways to children hospitalized with asthma.
是简明扼要、可操作的循证指南版本。研究表明,路径可改善因哮喘住院的儿童的护理质量,但我们对指导医院领导和临床医生实施路径的其他关键因素知之甚少。我们的目的是评估住院儿科哮喘路径的采用、实施和实施范围。
这是一项对参与全国合作实施路径的医院进行的混合方法研究。数据来源包括对实施领导人和工作人员的电子调查、现场观察以及对年龄在 2-17 岁、因哮喘主要诊断住院的儿童的病历回顾。结果包括医院采用的路径数量、路径因素以及哮喘住院儿童使用路径的比例。使用描述性统计和多变量回归分析对定量数据进行分析。对定性数据进行主题内容分析。
85 家医院参与了研究;68 家(80%)采用/完成了合作。这 68 家医院以总体高保真度实施了路径,中位数实施了 5 个核心路径组成部分中的 5 个(四分位距 [IQR] 4-5),中位数实施时间为 5 个月(IQR 3-9)。实施团队报告实施的中位数时间成本为 78 小时(IQR:40-120)。实施领导者报告路径实施的价值包括改善护理、加强跨学科合作以及获得教育资源。领导者报告在修改电子病历(EHR)方面存在障碍,只有 63%的儿童的电子路径医嘱得到了下达。
医院以高保真度实施了路径。修改 EHR 的障碍可能限制了哮喘住院儿童使用路径的范围。